RT Journal Article
T1 Impact of foot functionality in patients with systemic sclerosis: Cross-sectional study
A1 Chicharro-Luna, Esther
A1 Gracia-Vesga, Miguel Ángel
A1 Ramos Petersen, Laura
A1 Gijón-Noguerón, Gabriel
K1 Esclerodermia sistémica
K1 Pies - Lesiones y heridas
AB Progressive systemic sclerosis or systemic scleroderma (SS) is a chronic and rare autoimmune disease that mainly affects the skin and various internal organs. Raynaud's phenomenon and digital ulcers are some of the symptoms that affect the foot, causing a decrease in the quality of life of patients. The objective of this study is to determine the functionality of the feet in patients with SS and determine the impact on their daily lives.SS is a disease that affects foot functionality in patients, with a greater impact on the pain scale. There is a correlation between the final FFI score and the final SySQ score, so improving foot functionality could help to improve the overall functionality of the patient with sclerosis.
PB Elsevier
YR 2024
FD 2024
LK https://hdl.handle.net/10630/31338
UL https://hdl.handle.net/10630/31338
LA eng
NO Esther Chicharro-Luna, Miguel Ángel Gracia-Vesga, Laura Ramos-Petersen, Gabriel Gijón-Nogueron, Impact of foot functionality in patients with systemic sclerosis: Cross-sectional study, Journal of Tissue Viability, Volume 33, Issue 2, 2024, Pages 202-207, ISSN 0965-206X, https://doi.org/10.1016/j.jtv.2024.03.004.
NO Funding for open access charge: Universidad de Málaga / CBUA
DS RIUMA. Repositorio Institucional de la Universidad de Málaga
RD 22 ene 2026